BIO-RAD LABORATORIES, INC. Equity Method Investment, Other than Temporary Impairment
BIO-RAD LABORATORIES, INC. (BIO.B) reported Equity Method Investment, Other than Temporary Impairment of $6.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-13.
Financial Statements › Income Statement › Other Income
us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment · last filed 2026-02-13
- BIO-RAD LABORATORIES, INC. equity method investment, other than temporary impairment for the quarter ending 2025-12-31 was $0.00.
- BIO-RAD LABORATORIES, INC. equity method investment, other than temporary impairment for the quarter ending 2025-09-30 was $6.00M.
- BIO-RAD LABORATORIES, INC. equity method investment, other than temporary impairment for the quarter ending 2024-12-31 was $0.00.
- BIO-RAD LABORATORIES, INC. equity method investment, other than temporary impairment for the quarter ending 2024-09-30 was $0.00.
- BIO-RAD LABORATORIES, INC. equity method investment, other than temporary impairment for fiscal 2025 was $6.00M.
- BIO-RAD LABORATORIES, INC. equity method investment, other than temporary impairment for fiscal 2024 was $0.00.
- BIO-RAD LABORATORIES, INC. equity method investment, other than temporary impairment for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- BIO-RAD LABORATORIES, INC. equity method investment, other than temporary impairment for fiscal 2022 was $11.90M, a 1387.50% increase from fiscal 2021.
| Period end | Equity Method Investment, Other than Temporary Impairment 3 month | Equity Method Investment, Other than Temporary Impairment 6 month | Equity Method Investment, Other than Temporary Impairment 9 month | Equity Method Investment, Other than Temporary Impairment 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $6.00M derived: sum of 2 quarters · filed 2026-02-13 | $6.00M 10-K · filed 2026-02-13 | |
| 2025-09-30 | $6.00M 10-Q · filed 2025-10-29 | $6.00M 10-Q · filed 2025-10-29 | ||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $0.00 derived: sum of 2 quarters · filed 2026-02-13 | $0.00 10-K · filed 2026-02-13 | |
| 2024-09-30 | $0.00 10-Q · filed 2025-10-29 | $0.00 10-Q · filed 2025-10-29 | ||
| 2023-12-31 | $0.00 10-K · filed 2026-02-13 | |||
| 2022-12-31 | $11.90M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | $11.90M derived: sum of 2 quarters · filed 2025-02-14 | $11.90M derived: sum of 3 quarters · filed 2025-02-14 | $11.90M 10-K · filed 2025-02-14 |
| 2022-09-30 | $0.00 10-Q · filed 2022-10-28 | $0.00 derived: sum of 2 quarters · filed 2022-10-28 | $0.00 10-Q · filed 2022-10-28 | $0.00 derived: sum of 4 quarters · filed 2024-02-16 |
| 2022-06-30 | $0.00 10-Q · filed 2022-07-29 | $0.00 10-Q · filed 2022-07-29 | $0.00 derived: sum of 3 quarters · filed 2024-02-16 | $0.00 derived: sum of 4 quarters · filed 2024-02-16 |
| 2022-03-31 | $0.00 10-Q · filed 2022-04-29 | $0.00 derived: sum of 2 quarters · filed 2024-02-16 | $0.00 derived: sum of 3 quarters · filed 2024-02-16 | $0.00 derived: sum of 4 quarters · filed 2024-02-16 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-16 | $0.00 derived: sum of 2 quarters · filed 2024-02-16 | $0.00 derived: sum of 3 quarters · filed 2024-02-16 | $800.00K 10-K · filed 2024-02-16 |
| 2021-09-30 | $0.00 10-Q · filed 2022-10-28 | $0.00 derived: sum of 2 quarters · filed 2022-10-28 | $800.00K 10-Q · filed 2022-10-28 | $800.00K derived: sum of 4 quarters · filed 2023-02-17 |
| 2021-06-30 | $0.00 10-Q · filed 2022-07-29 | $800.00K 10-Q · filed 2022-07-29 | $800.00K derived: sum of 3 quarters · filed 2023-02-17 | $800.00K derived: sum of 4 quarters · filed 2023-02-17 |
| 2021-03-31 | $800.00K 10-Q · filed 2022-04-29 | $800.00K derived: sum of 2 quarters · filed 2023-02-17 | $800.00K derived: sum of 3 quarters · filed 2023-02-17 | $5.40M derived: sum of 4 quarters · filed 2023-02-17 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-17 | $0.00 derived: sum of 2 quarters · filed 2023-02-17 | $4.60M derived: sum of 3 quarters · filed 2023-02-17 | $4.60M 10-K · filed 2023-02-17 |
| 2020-09-30 | $0.00 10-Q · filed 2021-10-29 | $4.60M derived: sum of 2 quarters · filed 2021-10-29 | $4.60M 10-Q · filed 2021-10-29 | $8.80M derived: sum of 4 quarters · filed 2022-02-11 |
| 2020-06-30 | $4.60M 10-Q · filed 2021-07-30 | $4.60M 10-Q · filed 2021-07-30 | $8.80M derived: sum of 3 quarters · filed 2022-02-11 | $8.80M derived: sum of 4 quarters · filed 2022-02-11 |
| 2020-03-31 | $0.00 10-Q · filed 2021-04-30 | $4.20M derived: sum of 2 quarters · filed 2022-02-11 | $4.20M derived: sum of 3 quarters · filed 2022-02-11 | $4.20M derived: sum of 4 quarters · filed 2022-02-11 |
| 2019-12-31 | $4.20M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-11 | $4.20M derived: sum of 2 quarters · filed 2022-02-11 | $4.20M derived: sum of 3 quarters · filed 2022-02-11 | $5.80M 10-K · filed 2022-02-11 |
| 2019-09-30 | $0.00 10-Q · filed 2020-10-30 | $0.00 derived: sum of 2 quarters · filed 2020-10-30 | $1.60M 10-Q · filed 2020-10-30 | |
| 2019-06-30 | $0.00 10-Q · filed 2020-07-31 | $1.60M 10-Q · filed 2020-07-31 |